Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v1-EN
Language English English
Date Updated 2023-06-28 2023-05-30
Drug Identification Number 02490838 02490838
Brand name DAPTOMYCIN FOR INJECTION DAPTOMYCIN FOR INJECTION
Common or Proper name DAPTOMYCIN DAPTOMYCIN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients DAPTOMYCIN DAPTOMYCIN
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size LYVI LYVI
ATC code J01XX J01XX
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-30 2023-05-30
Estimated end date 2023-06-23 2023-06-02
Actual end date 2023-06-27
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments